Drugs / Mx-dnG1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00035919 | Nov 2002 → Oct 2003 | colorectal neoplasm | University of Southern California | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mx-dnG1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00035919 ↗ |
| Action | Inhibit | “a Dominant Negative Cyclin G1 Construct” NCT00035919 ↗ |
| Route | Other | “Hepatic arterial infusion of the Mx-dnG1 retroviral vector once a day on days 1-5” NCT00035919 ↗ |
| Target | CCNG1 | “Matrix-Targeted Retroviral Vector Bearing a Dominant Negative Cyclin G1 Construct” NCT00035919 ↗ |